Street Capital Inc.
REZNF
Other OTC0.00
USD
- -
- -
ISIN
CA86326R1064
CUSIP
86326R106
Return %
Stock
S&P500
1Y
-99.00
26.84
3Y
-96.61
77.03
5Y
-99.19
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Chris Savoie
- Full Time Employees
- 72
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1 Adelaide Street East Toronto ON Canada M5C 2V9
- IPO Date
- Sep 24, 2021
- Website
- thehashcorporation.com
- Similar Companies
- Business
- Street Capital Inc. (Ticker: REZNF) focuses on the production and sale of cannabis-based hashish and other premium cannabis resin products in Canada. The company applies proprietary separation and curing techniques to create a suite of natural cannabis resin products free of additives, including authentic hashish offerings such as bubble hash and rosin crafted through collaborations with licensed cultivators and micro-license partners across the country; it sources resin from passionate farmers to deliver consistent, high-quality products compliant with modern safety regulations for regulated markets like the Ontario Cannabis Store and licensed dispensaries. Incorporated in 1967 and headquartered at 1 Adelaide Street East in Toronto, Ontario, Street Capital Inc. operates within the medicinal chemicals and botanical products industry, targeting the Canadian cannabis consumer market. In a significant strategic shift during 2024, the company, formerly known as The Hash Corporation, closed the sale of substantially all its assets—including physical inventory, intellectual property, licenses, and customer relationships—to 1000592191 Ontario Inc. for CAD 350,000 plus the value of inventory on closing in May 2024, followed by a name change to Street Capital Inc. and a ticker symbol update to STRC.X effective November 19, 2024. This transaction, approved as a related party deal, repositioned the company to pursue new acquisition or merger opportunities to maximize shareholder value, with plans to raise additional capital for such initiatives. Earlier efforts included completing first commercial batches with collaborator Black Rose Organics Canada Inc. in 2021 and fully prepaying a convertible debenture to Stock Trend Capital Inc. in 2023.